[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:hepatic-steatosis":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":61,"states":62},"Hepatic Steatosis",8,6,[8,16,23,29,35,41,47,54],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07610837","Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis",[12],"Phase 2","RECRUITING","2026-08-26T02:15:37.042762Z","2026-05-29T15:36:40.229381Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07358546","A Study of Efimosfermin Alfa in Adults With Hepatic Impairment",[20],"Phase 1","2026-08-26T02:16:54.876240Z","2026-07-05T05:32:16.678763Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07192159","Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD",[],"2026-08-26T02:16:01.910993Z","2026-05-05T02:43:26.688932Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT07495332","Siemens Biomarker Multi-modality",[],"2026-08-26T02:16:26.411851Z","2026-05-05T02:35:31.708019Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT07191561","Hepatic Lipid Metabolism-Alcohol Use Disorder",[],"2026-08-26T02:16:27.227548Z","2026-05-13T02:55:06.670839Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT06993454","Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis",[],"2026-08-26T02:18:19.586423Z","2026-05-05T02:47:14.270773Z",{"nct_id":48,"title":49,"phases":50,"status":51,"updated_at":52,"content_modified":53},"NCT07634939","Liver Micro Flow - MRI",[],"NOT_YET_RECRUITING","2026-08-26T02:18:17.007929Z","2026-06-14T18:39:22.253083Z",{"nct_id":55,"title":56,"phases":57,"status":58,"updated_at":59,"content_modified":60},"NCT06944353","Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED",[],"ENROLLING_BY_INVITATION","2026-08-26T02:18:39.640967Z","2026-05-05T02:47:14.272123Z",[],[63],{"state":64,"count":65,"slug":66},"Florida",3,"florida"]